Rephonic
Artwork for Prostate Cancer Update

Prostate Cancer Update

Dr. Neil Love
Prostate Cancer
Pembrolizumab
Urothelial Bladder Cancer
Immunotherapy
Renal Cell Carcinoma
Clinical Trials
Urethral Bladder Cancer
Hormonal Therapy
Androgen Receptor Pathway Inhibitors
PARP Inhibitors
Metastatic Urothelial Bladder Cancer
AKT Inhibitors
EMBARQ Study
Chemotherapy
Bladder Cancer
Antibody-Drug Conjugates
HER2
Tar-200
P10 Deficiency
Nivolumab

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing urologists and radiation oncologists ongoing access to the perspectives and opinions of national and international prostate cancer research leaders.

PublishesTwice weeklyEpisodes178Founded20 years ago
Number of ListenersCategories
MedicineHealth & FitnessScience

Listen to this Podcast

Artwork for Prostate Cancer Update

Latest Episodes

Featuring an interview with Dr Rana R McKay, including the following topics:

• Prostate Cancer Working Group (PCWG4) revised terminology (0:00)

• Cardiovascular effects associated with GnRH agonists versus antagonists; mechanism of action (2:17)

• C... more

YouTube

Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics:

• Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Canc... more

YouTube

Featuring perspectives from Dr Ashish M Kamat and Prof Thomas Powles, including the following topics:

• Introduction: Life After Radical Cystectomy (0:00)

• Muscle-Invasive Bladder Cancer — Prof Powles (9:15)

• Non-Muscle-Invasive Bladder Cancer — D... more

YouTube

Featuring perspectives from Dr Neeraj Agarwal and Dr Alan H Bryce, including the following topics:

• Introduction (0:00)

• Optimizing the Role of Hormonal Therapy in the Care of Patients with Prostate Cancer — Dr Bryce (2:41)

• Other Available and E... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Two Onc Docs
Two Onc DocsSam and Karine
Lung Cancer Update
Lung Cancer UpdateDr. Neil Love

Recent Guests

Ashish Kamat
Medical oncologist from the University of Texas, MD Anderson Cancer Center
University of Texas, MD Anderson Cancer Center
Episode: Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
Tom Powles
Professor at Barts Cancer Institute, Queen Mary University of London
Barts Cancer Institute, Queen Mary University of London
Episode: Urothelial Bladder Cancer — Year in Review Series on Relevant New Datasets and Advances
Terry Friedlander
Physician from UCSF Helen Diller Comprehensive Cancer Center
UCSF Helen Diller Comprehensive Cancer Center
Episode: Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Dan Petrylak
Physician from Yale Comprehensive Cancer Center
Yale Comprehensive Cancer Center
Episode: Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Gus Fonseca
Clinician with Florida Cancer Specialists
Florida Cancer Specialists
Episode: Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Dr. Andrew Armstrong
Oncologist contributing questions and context
Episode: Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting
Thomas Powles
Professor, Barts Cancer Institute, Queen Mary University of London
Barts Cancer Institute, Queen Mary University of London
Episode: Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Dr. Wassim Abida
Memorial Sloan Kettering Cancer Center clinician
Memorial Sloan Kettering Cancer Center
Episode: PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida
Matt Milowsky
Oncologist discussing metastatic urothelial bladder cancer cases
University of North Carolina, Lindbergh Comprehensive Cancer Center
Episode: Metastatic Bladder Cancer — Rapid Case Review Issue 4

Host

Dr. Neil Love
Medical oncologist and host with long-running roles in oncology education and updates.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#218
Belgium/Science

Talking Points

Recent interactions between the hosts and their guests.

Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Q: Given the toxicity signals with combination regimens, how do you balance upfront toxicity with long-term benefit?
The panel discusses weighing higher early toxicity against potential long-term benefits, with emphasis on selecting patients carefully, optimizing dosing cycles, and considering alternative sequences like monotherapy or different targeted approaches when toxicity risks rise.
Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit
Q: Dan, what were your highlights of the year?
Dr. Petrylak points to EV Pembrolizumab studies opening new treatment frontiers for cisplatin-eligible and ineligible patients, the dramatic improvements in complete response rates, median survival, and the potential of ctDNA to guide adjuvant decisions.
Genitourinary Cancers — 5-Minute Journal Club Issue 1 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
Q: How does ctDNA positivity compare to PSA in guiding decisions for bladder cancer, and what are the practical implications for adjuvant therapy?
ctDNA provides a real-time, dynamic risk assessment that complements imaging. While PSA has long guided prostate cancer decisions, ctDNA offers a similar, time-sensitive signal in bladder cancer, enabling you to identify high-risk patients who may benefit from adjuvant immunotherapy and avoid overtreating those at low risk.
Metastatic Bladder Cancer — Rapid Case Review Issue 2
Q: When you're giving urtifitinib, how often are you having to do dose reductions to manage to keep patients on therapy?
Dose reductions are often necessary due to adverse effects, such as hand-foot syndrome.
Metastatic Bladder Cancer — Rapid Case Review Issue 2
Q: How do you manage these adverse effects associated with n-fortum-ab-vidotin, notably rash and neuropathy?
Adverse effects are typically managed with topical steroids and dose adjustments.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Prostate Cancer Update

What is Prostate Cancer Update about and what kind of topics does it cover?

This show serves as a practical, clinician-focused briefing on prostate cancer research and care, featuring in-depth one-on-one interviews with leading urologic and medical oncologists. Across recent episodes, conversations center on integrating new data into patient management—covering biomarker-driven decisions, biomarker testing strategies, perioperative and metastatic approaches, trial data interpretation, and the evolving role of immunotherapies and targeted agents in both hormone-sensitive and advanced disease. A standout aspect is the emphasis on real-world case discussions and actionable takeaways for sequencing treatments, handling toxicities, and personalizing therapy through molecular profiling, often with international perspecti... more

Where can I find podcast stats for Prostate Cancer Update?

Rephonic provides a wide range of podcast stats for Prostate Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Prostate Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Prostate Cancer Update get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Prostate Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Prostate Cancer Update?

Rephonic provides comprehensive predictive audience data for Prostate Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Prostate Cancer Update have?

To see how many followers or subscribers Prostate Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Prostate Cancer Update?

These podcasts share a similar audience with Prostate Cancer Update:

1. ASCO Daily News
2. Two Onc Docs
3. Gastrointestinal Cancer Update
4. Lung Cancer Update
5. Breast Cancer Update

How many episodes of Prostate Cancer Update are there?

Prostate Cancer Update launched 20 years ago and published 178 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Prostate Cancer Update?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Prostate Cancer Update?

Rephonic pulls ratings and reviews for Prostate Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Prostate Cancer Update?

Rephonic provides full transcripts for episodes of Prostate Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Prostate Cancer Update?

Recent guests on Prostate Cancer Update include:

1. Ashish Kamat
2. Tom Powles
3. Terry Friedlander
4. Dan Petrylak
5. Gus Fonseca
6. Dr. Andrew Armstrong
7. Thomas Powles
8. Dr. Wassim Abida

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days